Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
Source link
More Articles Like This
- Advertisement -
Category
Links
Stay connected
Mail us : thetimes365@thetimes365.com
Newsletter Signup
- Advertisement -
© thetimes365 | All rights reserved.